Quality control in the endoplasmic reticulum, Nature Reviews Molecular Cell Biology, vol.418, issue.3, pp.181-91, 2003. ,
DOI : 10.1038/nrm1052
Protein quality control in the early secretory pathway, The EMBO Journal, vol.18, issue.2, pp.315-342, 2008. ,
DOI : 10.1038/sj.emboj.7601974
Chaperons moléculaires et repliement des protéines, Med Sci, vol.21, pp.619-644, 2005. ,
Retro-translocation of proteins from the endoplasmic reticulum into the cytosol, Nature Reviews Molecular Cell Biology, vol.1, issue.4, pp.246-55, 2002. ,
DOI : 10.1038/nrm780
Therapeutic approaches to protein-misfolding diseases, Nature, vol.426, issue.6968, pp.905-914, 2003. ,
DOI : 10.1038/nature02265
Protein-misfolding diseases and chaperone-based therapeutic approaches, FEBS Journal, vol.94, issue.9364, pp.1331-1380, 2006. ,
DOI : 10.1016/S0165-6147(00)01575-3
The Cystic Fibrosis Transmembrane Conductance Regulator, Annual Review of Physiology, vol.55, issue.1, pp.609-639, 1993. ,
DOI : 10.1146/annurev.ph.55.030193.003141
Identification of the cystic fibrosis gene: genetic analysis, Science, vol.245, issue.4922, pp.1073-1080, 1989. ,
DOI : 10.1126/science.2570460
de la découverte des lysosomes à l'avènement de la thérapeutique Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor, Med Sci Nature Med, vol.21, issue.5, pp.5-7, 1999. ,
Gaucher Disease, Adv Hum Genet, vol.21, pp.377-441, 1993. ,
DOI : 10.1007/978-1-4615-3010-7_5
Nonlinear partial differential equations and applications: Chemical chaperones increase the cellular activity of N370S ??-glucosidase: A therapeutic strategy for Gaucher disease, Proceedings of the National Academy of Sciences, vol.99, issue.24, pp.15428-15461, 2002. ,
DOI : 10.1073/pnas.192582899
G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo, Pharmacological Reviews, vol.59, issue.3, pp.225-50, 2007. ,
DOI : 10.1124/pr.59.3.2
Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy, Trends in Molecular Medicine, vol.11, issue.4, pp.177-85, 2005. ,
DOI : 10.1016/j.molmed.2005.02.007
Nephrogenic Diabetes Insipidus, Annual Review of Physiology, vol.63, issue.1, pp.607-637, 2001. ,
DOI : 10.1146/annurev.physiol.63.1.607
Drug development and the cellular quality control system, Trends in Pharmacological Sciences, vol.30, issue.5, pp.228-261, 2009. ,
DOI : 10.1016/j.tips.2009.02.002
Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation, Journal of Biological Chemistry, vol.271, issue.2, pp.635-673, 1996. ,
DOI : 10.1074/jbc.271.2.635
Rescue of a Nephrogenic Diabetes Insipidus-causing Vasopressin V2 Receptor Mutant by Cell-penetrating Peptides, Journal of Biological Chemistry, vol.282, issue.28, pp.20676-85, 2007. ,
DOI : 10.1074/jbc.M611530200
Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators, Journal of Biological Chemistry, vol.272, issue.2, pp.709-721, 1997. ,
DOI : 10.1074/jbc.272.2.709
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants, Journal of Clinical Investigation, vol.105, issue.7, pp.887-95, 2000. ,
DOI : 10.1172/JCI8688
Pharmacologic Chaperones as a Potential Treatment for X-Linked Nephrogenic Diabetes Insipidus, Journal of the American Society of Nephrology, vol.17, issue.1, pp.232-275, 2006. ,
DOI : 10.1681/ASN.2005080854
Biased Agonist Pharmacochaperones of the AVP V2 Receptor May Treat Congenital Nephrogenic Diabetes Insipidus, Journal of the American Society of Nephrology, vol.20, issue.10, pp.2190-203, 2009. ,
DOI : 10.1681/ASN.2008121289
URL : https://hal.archives-ouvertes.fr/inserm-00421838
Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus, AJP: Renal Physiology, vol.292, issue.1, pp.253-260, 2007. ,
DOI : 10.1152/ajprenal.00247.2006
Effect of vitamine A supplementation on rhodopsin mutants T17M and P347S in transgenic mice and in cell cultures, pp.11933-11971, 1998. ,
Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation, The EMBO Journal, vol.21, issue.7, pp.1628-1665, 2002. ,
DOI : 10.1093/emboj/21.7.1628
Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine, Molecular and Cellular Endocrinology, vol.298, issue.1-2, pp.84-88, 2009. ,
DOI : 10.1016/j.mce.2008.09.015
??1-Antitrypsin Deficiency, Chest, vol.110, issue.6, pp.243-290, 1996. ,
DOI : 10.1378/chest.110.6_Supplement.243S
R??activation de p53 dans les tumeurs : une strat??gie antitumorale prometteuse, m??decine/sciences, vol.23, issue.6-7, pp.565-67, 2007. ,
DOI : 10.1051/medsci/20072367565
A frequent activated smoothened mutation in sporadic basal cell carcinomas, Oncogene, vol.18, issue.3, pp.833-869, 1999. ,
DOI : 10.1038/sj.onc.1202360
Identification and Pharmacological Correction of a Membrane Trafficking Defect Associated with a Mutation in the Sulfonylurea Receptor Causing Familial Hyperinsulinism, Journal of Biological Chemistry, vol.276, issue.38, pp.35947-52, 2001. ,
DOI : 10.1074/jbc.M104762200
Sulfonylurea Receptor 1 Mutations That Cause Opposite Insulin Secretion Defects with Chemical Chaperone Exposure, Journal of Biological Chemistry, vol.284, issue.12, pp.7951-59, 2009. ,
DOI : 10.1074/jbc.M807012200
A Conditional Mutation Affecting Localization of the Menkes Disease Copper ATPase. SUPPRESSION BY COPPER SUPPLEMENTATION, Journal of Biological Chemistry, vol.277, issue.46, pp.44079-84, 2002. ,
DOI : 10.1074/jbc.M208737200
Structure and function in rhodopsin: correct folding and misfolding in two point mutants in the intradiscal domain of rhodopsin identified in retinitis pigmentosa., Proceedings of the National Academy of Sciences, vol.93, issue.10, pp.4554-59, 1996. ,
DOI : 10.1073/pnas.93.10.4554
Functional characterization of three mutations of the endothelin B receptor gene in patients with Hirshsprung's disease : evidence for selective loss of Gi coupling, Mol Med, vol.7, pp.115-139, 2001. ,
Melanocortin 4 Receptor Mutations in a Large Cohort of Severely Obese Adults: Prevalence, Functional Classification, Genotype-Phenotype Relationship, and Lack of Association with Binge Eating, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.5, pp.1811-1829, 2006. ,
DOI : 10.1210/jc.2005-1411
URL : https://hal.archives-ouvertes.fr/hal-00427994
Inherited ACTH insensitivity illuminates the mechanisms of ACTH action, Trends in Endocrinology & Metabolism, vol.16, issue.10, pp.451-57, 2005. ,
DOI : 10.1016/j.tem.2005.10.006
Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene, Nature, vol.382, issue.6593, pp.722-747, 1996. ,
DOI : 10.1038/382722a0
THE CALCIUM-SENSING RECEPTOR IN NORMAL PHYSIOLOGY AND PATHOPHYSIOLOGY: A Review, Critical Reviews in Clinical Laboratory Sciences, vol.111, issue.2, pp.35-70, 2007. ,
DOI : 10.1172/JCI9038
Mutations of the Human Thyrotropin Receptor Gene Causing Thyroid Hypoplasia and Persistent Congenital Hypothyroidism, Journal of Clinical Endocrinology & Metabolism, vol.82, issue.10, pp.3471-80, 1997. ,
DOI : 10.1210/jc.82.10.3471
Activating and inactivating mutations in LH receptors, Molecular and Cellular Endocrinology, vol.145, issue.1-2, pp.137-179, 1998. ,
DOI : 10.1016/S0303-7207(98)00180-4
Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure, Cell, vol.82, issue.6, pp.959-68, 1995. ,
DOI : 10.1016/0092-8674(95)90275-9
Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk, Human Molecular Genetics, vol.14, issue.15, pp.2145-54, 2005. ,
DOI : 10.1093/hmg/ddi219
Retinoids Assist the Cellular Folding of the Autosomal Dominant Retinitis Pigmentosa Opsin Mutant P23H, Journal of Biological Chemistry, vol.279, issue.16, pp.16278-84, 2004. ,
DOI : 10.1074/jbc.M312101200
THERAPEUTIC STRATEGIES FOR HUMAN AMYLOID DISEASES, Nature Reviews Drug Discovery, vol.1, issue.4, pp.267-75, 2002. ,
DOI : 10.1038/35089090
-Adrenoceptor Dimerization and Trafficking by Pharmacological Chaperones, Traffic, vol.13, issue.8, pp.1019-1052, 2009. ,
DOI : 10.1111/j.1600-0854.2009.00932.x
URL : https://hal.archives-ouvertes.fr/hal-00409826
Small-molecule modulators of the Sonic Hedgehog signaling pathway, Mol. BioSyst., vol.106, issue.1, pp.44-54, 2010. ,
DOI : 10.1039/B910196A
Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria, Journal of Clinical Investigation, vol.118, issue.8, pp.2858-67, 2008. ,
DOI : 10.1172/JCI34355
In vitro inhibition and intracellular enhancement of lysosomal ??-galactosidase???A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives, European Journal of Biochemistry, vol.262, issue.13, pp.4179-86, 2000. ,
DOI : 10.1046/j.1432-1327.2000.01457.x
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease, Proc. Natl. Acad. Sci. USA, pp.9836-9877, 2001. ,
DOI : 10.1073/pnas.161274798
In Vivo Reversal of Amyloid-?? Lesions in Rat Brain, Journal of Neuropathology & Experimental Neurology, vol.59, issue.1, pp.11-17, 2000. ,
DOI : 10.1093/jnen/59.1.11
Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy, Proc. Natl. Acad. Sci. USA, pp.6739-6783, 2000. ,
DOI : 10.1073/pnas.110138997